Susannah Stanway

3.1k total citations · 2 hit papers
38 papers, 1.5k citations indexed

About

Susannah Stanway is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Susannah Stanway has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 10 papers in Pulmonary and Respiratory Medicine and 9 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Susannah Stanway's work include Estrogen and related hormone effects (8 papers), Cancer survivorship and care (7 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Susannah Stanway is often cited by papers focused on Estrogen and related hormone effects (8 papers), Cancer survivorship and care (7 papers) and Chemotherapy-induced cardiotoxicity and mitigation (7 papers). Susannah Stanway collaborates with scholars based in United Kingdom, United States and Sweden. Susannah Stanway's co-authors include Krishnan Bhaskaran, Liam Smeeth, Helena Carreira, Alexander R. Lyon, Anthony Matthews, Rachael Williams, Helen Strongman, Isabel dos‐Santos‐Silva, Rhea Harewood and Martín Müller and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and JNCI Journal of the National Cancer Institute.

In The Last Decade

Susannah Stanway

37 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases

2019 334 citations Helen Strongman, Sarah Gadd et al. The Lancet profile →
Associations Between Breast Cancer Survivorship and Adverse Mental Health Outcomes: A Systematic Review

2018 256 citations Helena Carreira, Rachael Williams et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Susannah Stanway United Kingdom	16	681	386	351	293	242	38	1.5k
Luigi Santoro Italy	26	679 1.0×	589 1.5×	318 0.9×	143 0.5×	160 0.7×	77	2.3k
Ashley S. Felix United States	28	741 1.1×	218 0.6×	146 0.4×	280 1.0×	359 1.5×	102	2.7k
Susan Dent Canada	27	1.1k 1.6×	259 0.7×	313 0.9×	271 0.9×	315 1.3×	81	2.1k
Changchuan Jiang United States	18	450 0.7×	421 1.1×	269 0.8×	55 0.2×	243 1.0×	98	1.6k
F Pannuti Italy	23	766 1.1×	294 0.8×	233 0.7×	226 0.8×	213 0.9×	122	1.5k
Raymond Ng Singapore	22	564 0.8×	85 0.2×	599 1.7×	209 0.7×	165 0.7×	56	1.5k
Petra H. Peeters Netherlands	24	910 1.3×	112 0.3×	336 1.0×	149 0.5×	218 0.9×	43	1.6k
Corrado Ficorella Italy	27	1.2k 1.7×	262 0.7×	651 1.9×	118 0.4×	584 2.4×	140	2.6k
Dexter L. Cooper United States	13	1.2k 1.7×	125 0.3×	602 1.7×	126 0.4×	739 3.1×	25	2.8k
Paul Carter United Kingdom	22	473 0.7×	165 0.4×	187 0.5×	337 1.2×	275 1.1×	35	1.7k

Countries citing papers authored by Susannah Stanway

Since Specialization

Citations

This map shows the geographic impact of Susannah Stanway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susannah Stanway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susannah Stanway more than expected).

Fields of papers citing papers by Susannah Stanway

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susannah Stanway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susannah Stanway. The network helps show where Susannah Stanway may publish in the future.

Co-authorship network of co-authors of Susannah Stanway

This figure shows the co-authorship network connecting the top 25 collaborators of Susannah Stanway. A scholar is included among the top collaborators of Susannah Stanway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susannah Stanway. Susannah Stanway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ghose, Aruni, Katie Wakeham, N.S. Dhillon, et al.. (2024). Early adoption of innovation in HPV prevention strategies: closing the gap in cervical cancer. ecancermedicalscience. 18. 1762–1762. 3 indexed citations

Strongman, Helen, Emily Herrett, Rod Jackson, et al.. (2022). Cancer history as a predictor in cardiovascular risk scores: a primary care cohort study. British Journal of General Practice. 73(726). e34–e42. 6 indexed citations

Strongman, Helen, Sarah Gadd, Anthony Matthews, et al.. (2022). Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?. JACC CardioOncology. 4(1). 113–123. 47 indexed citations

Battisti, Nicolò Matteo Luca, María Sol Andrés, Karla A. Lee, et al.. (2021). Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer. Breast Cancer Research and Treatment. 188(1). 149–163. 45 indexed citations

Stanway, Susannah, Mark Lodge, Richard Sullivan, et al.. (2021). The UK's contribution to cancer control in low-income and middle-income countries. The Lancet Oncology. 22(9). e410–e418. 13 indexed citations

Matthews, Anthony, Sharon Peacock Hinton, Susannah Stanway, et al.. (2020). Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors. Heart. 107(16). 1327–1335. 31 indexed citations

Carreira, Helena, et al.. (2020). Quality of life and mental health in breast cancer survivors compared with non-cancer controls: a study of patient-reported outcomes in the United Kingdom. Journal of Cancer Survivorship. 15(4). 564–575. 70 indexed citations

Carreira, Helena, Helen Strongman, Helen McDonald, et al.. (2020). Prevalence of COVID-19-related risk factors and risk of severe influenza outcomes in cancer survivors: A matched cohort study using linked English electronic health records data. EClinicalMedicine. 29-30. 100656–100656. 40 indexed citations

Angelis, Vasileios, Zayd Tippu, Kroopa Joshi, et al.. (2020). Defining the true impact of coronavirus disease 2019 in the at-risk population of patients with cancer. European Journal of Cancer. 136. 99–106. 21 indexed citations

10.

Lidington, Emma, Sophie McGrath, Jillian Noble, et al.. (2020). Evaluating a digital tool for supporting breast cancer patients: a randomized controlled trial protocol (ADAPT). Trials. 21(1). 86–86. 11 indexed citations

11.

Strongman, Helen, Sarah Gadd, Anthony Matthews, et al.. (2019). Medium and long-term risks of specific cardiovascular diseases in survivors of 20 adult cancers: a population-based cohort study using multiple linked UK electronic health records databases. The Lancet. 394(10203). 1041–1054. 334 indexed citations breakdown →

12.

Bromley, Susan, Anthony Matthews, Liam Smeeth, Susannah Stanway, & Krishnan Bhaskaran. (2019). Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK. Journal of Cancer Survivorship. 13(4). 632–640. 12 indexed citations

13.

Carreira, Helena, Rachael Williams, Garth Funston, Susannah Stanway, & Krishnan Bhaskaran. (2019). Risk of anxiety and depression in breast cancer survivors compared to women who have never had cancer: A population-based cohort study in the United Kingdom.. Journal of Clinical Oncology. 37(15_suppl). 1564–1564. 3 indexed citations

14.

Sirohi, Bhawna, Kalipso Chalkidou, C.S. Pramesh, et al.. (2018). Developing institutions for cancer care in low-income and middle-income countries: from cancer units to comprehensive cancer centres. The Lancet Oncology. 19(8). e395–e406. 35 indexed citations

15.

Matthews, Anthony, Susannah Stanway, Ruth Farmer, et al.. (2018). Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic review. BMJ. 363. k3845–k3845. 85 indexed citations

16.

Yousaf, Nadia, S.J. Harris, Juan Martín-Liberal, et al.. (2015). First line palliative chemotherapy in elderly patients with advanced soft tissue sarcoma. PubMed. 5(1). 10–10. 10 indexed citations

17.

Gennatas, Spyridon, Susannah Stanway, R. Gunapala, et al.. (2015). Patterns of relapse in extrapulmonary small cell carcinoma: retrospective analysis of outcomes from two cancer centres. BMJ Open. 5(1). e006440–e006440. 17 indexed citations

18.

Banerjee, Susana & Susannah Stanway. (2015). Problem solving in acute oncology. British Journal of Cancer. 113(12). 1744–1745. 2 indexed citations

19.

Sharma, Bhupinder, et al.. (2012). Imaging in oncology—over a century of advances. Nature Reviews Clinical Oncology. 9(12). 728–737. 20 indexed citations

20.

Stanway, Susannah, A. Purohit, L. W. Lawrence Woo, et al.. (2004). First phase I trial of a steroid sulfatase inhibitor in breast cancer. Journal of Clinical Oncology. 22(14_suppl). 645–645. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact